Cyclohexanecarboxylic Acids
"Cyclohexanecarboxylic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Carboxylic acid derivatives of cyclohexane.
Descriptor ID |
D003509
|
MeSH Number(s) |
D02.241.223.268 D02.455.426.392.368.367.218
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cyclohexanecarboxylic Acids".
Below are MeSH descriptors whose meaning is more specific than "Cyclohexanecarboxylic Acids".
This graph shows the total number of publications written about "Cyclohexanecarboxylic Acids" by people in this website by year, and whether "Cyclohexanecarboxylic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
2001 | 3 | 0 | 3 |
2004 | 2 | 0 | 2 |
2005 | 0 | 1 | 1 |
2007 | 3 | 0 | 3 |
2008 | 1 | 3 | 4 |
2009 | 4 | 0 | 4 |
2010 | 1 | 0 | 1 |
2011 | 2 | 0 | 2 |
2013 | 1 | 0 | 1 |
2016 | 2 | 0 | 2 |
2017 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cyclohexanecarboxylic Acids" by people in Profiles.
-
Wenzel AG, Reiner JL, Kohno S, Wolf BJ, Brock JW, Cruze L, Newman RB, Kucklick JR. Biomonitoring of emerging DINCH metabolites in pregnant women in charleston, SC: 2011-2014. Chemosphere. 2021 Jan; 262:128369.
-
Goodman CW, Brett AS. Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern? N Engl J Med. 2017 Aug 03; 377(5):411-414.
-
Sherman BJ, McRae-Clark AL. Treatment of Cannabis Use Disorder: Current Science and Future Outlook. Pharmacotherapy. 2016 05; 36(5):511-35.
-
Mariani JJ, Malcolm RJ, Mamczur AK, Choi JC, Brady R, Nunes E, Levin FR. Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients. Am J Drug Alcohol Abuse. 2016 05; 42(3):333-40.
-
Schacht JP, Anton RF, Randall PK, Li X, Henderson S, Myrick H. Effects of a GABA-ergic medication combination and initial alcohol withdrawal severity on cue-elicited brain activation among treatment-seeking alcoholics. Psychopharmacology (Berl). 2013 Jun; 227(4):627-37.
-
Schacht JP, Randall PK, Waid LR, Baros AM, Latham PK, Wright TM, Myrick H, Anton RF. Neurocognitive performance, alcohol withdrawal, and effects of a combination of flumazenil and gabapentin in alcohol dependence. Alcohol Clin Exp Res. 2011 Nov; 35(11):2030-8.
-
Anton RF, Myrick H, Wright TM, Latham PK, Baros AM, Waid LR, Randall PK. Gabapentin combined with naltrexone for the treatment of alcohol dependence. Am J Psychiatry. 2011 Jul; 168(7):709-17.
-
Moraska AR, Atherton PJ, Szydlo DW, Barton DL, Stella PJ, Rowland KM, Schaefer PL, Krook J, Bearden JD, Loprinzi CL. Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB. J Support Oncol. 2010 May-Jun; 8(3):128-32.
-
Haney AL, Garner SS, Cox TH. Gabapentin therapy for pain and irritability in a neurologically impaired infant. Pharmacotherapy. 2009 Aug; 29(8):997-1001.
-
Anton RF, Myrick H, Baros AM, Latham PK, Randall PK, Wright TM, Stewart SH, Waid R, Malcolm R. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009 Aug; 29(4):334-42.